OSSIO vs athenahealth
Side-by-side comparison of AI visibility scores, market position, and capabilities
OSSIO is an orthopedic medical device company offering biocomposite fixation implants that resorb and are replaced by natural bone; OSSIOfiber technology avoids metal implant removal surgeries; raised $72M+ in total funding;
About
OSSIO is a medical device company founded in 2015 and headquartered in Andover, Massachusetts, that develops biocomposite orthopedic fixation implants as an alternative to traditional metal hardware. The company's proprietary OSSIOfiber technology platform combines a bioabsorbable polymer matrix reinforced with mineral fibers to create implants that are strong enough to stabilize bone during healing, yet gradually resorb and are replaced by the patient's own natural bone tissue over time. This eliminates the need for a second surgery to remove metal hardware — a common procedure with titanium screws and plates — reducing total patient burden and healthcare costs. OSSIOfiber implants are FDA-cleared for use in the foot, ankle, and hand.
$1.7B annual revenue; 160K+ providers, 117M patients; 18.15% EHR market share; 6,713+ companies using 2025; acquired by Bain Capital & Hellman & Friedman Nov 2021 at $17B; AI interoperability 2025
About
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on the principle that healthcare administration should be managed as a service — with athenahealth absorbing the complexity of payer rule updates, regulatory compliance, and billing workflows so that physicians and clinical staff can focus entirely on patient care. Its cloud-native architecture, deployed before most EHR competitors moved to the cloud, remains a core technical differentiator.\n\nathenahealth's platform — athenaOne — integrates EHR, revenue cycle management, patient engagement, and care coordination in a single system used by over 160,000 providers across 117 million patient records. The company serves ambulatory practices ranging from solo physicians to large health systems and medical groups. Its continuously updated rules engine processes millions of payer transactions daily, enabling higher clean claim rates and faster reimbursement compared to on-premise EHR alternatives. athenahealth holds an 18.15% share of the US ambulatory EHR market.\n\nathenahealth is currently owned by a private equity consortium of Bain Capital and Hellman & Friedman, which acquired the company in 2019 for $5.7 billion. Annual revenue stands at approximately $1.7 billion. The company competes with Epic, eClinicalWorks, and Oracle Health in the ambulatory EHR market. Its managed-service model, shared payer network data, and cloud-native infrastructure continue to make it a compelling choice for ambulatory providers who prioritize revenue cycle performance and reduced administrative burden.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.